Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients

Bibliography

• Lee WM. Etiologies of acute liver failure. Semin Liver Dis 2008;28:142-52
   PubMed Web of Science ®Google Scholar
• MacDonald JS, Robertson RT. Toxicity testing in the 21st century: a view from the pharmaceutical industry. Toxicol Sci 2009;110:40-6
   PubMed Web of Science ®Google Scholar
• Antoine DJ, Jenkins RE, Dear JW, et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012;56:1070-9
   PubMed Web of Science ®Google Scholar
• McGill MR, Lee WM, Jaeschke H. Serum biomarkers of mitochondrial damage in survivors and non-survivors of acetaminophen-induced acute liver failure: implications for the mechanism of hepatotoxicity in humans [abstract]. Toxicologist (Toxicol Sci Suppl) 2014;138:224
   Google Scholar
• Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-94
   PubMed Web of Science ®Google Scholar
• Nelson SD. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 1990;10:267-78
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 2013;30:2174-87
   PubMed Web of Science ®Google Scholar
• Cohen SD, Khairallah EA. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 1997;29:59-77
   PubMed Web of Science ®Google Scholar
• Muldrew KL, James LP, Coop L, et al. Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos 2002;30:446-51
   PubMed Web of Science ®Google Scholar
• McGill MR, Lebosfky M, Norris HR, et al. Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol Appl Pharmacol 2013;269:240-9
   PubMed Web of Science ®Google Scholar
• Tirmenstein MA, Nelson SD. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3’-hydroxyacetanilide, in mouse liver. J Biol Chem 1989;264:9814-19
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Maeda S, Hikiba Y, et al. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology 2008;135:1311-21
   PubMed Web of Science ®Google Scholar
• Sharma M, Gadang V, Jaeschke A. Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity. Mol Pharmacol 2012;82:1001-7
   PubMed Web of Science ®Google Scholar
• Ramachandran A, McGill MR, Xie Y, et al. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 2013;58:2099-108
   PubMed Web of Science ®Google Scholar
• Hanawa N, Shinohara M, Saberi B, et al. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 2008;283:13565-77
   PubMed Web of Science ®Google Scholar
• Saito C, Lemasters JJ, Jaeschke H. c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2010;246:8-17
   PubMed Web of Science ®Google Scholar
• Kon K, Kim JS, Jaeschke H, Lemasters JJ. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 2004;40:1170-9
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Lebofsky M, Baines CP, et al. Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic Res 2011;45:156-64
   PubMed Web of Science ®Google Scholar
• Gujral JS, Knight TR, Farhood A, et al. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 2002;67:322-8
   PubMed Web of Science ®Google Scholar
• Saito C, Zwingmann C, Jaeschke H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology 2010;51:246-54
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Lebofsky M, Weinman SA, et al. The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2011;251:226-33
   PubMed Web of Science ®Google Scholar
• Agarwal R, Hennings L, Rafferty TM, et al. Acetaminophen-induced hepatotoxicity and protein nitration in neuronal nitric-oxide synthase knockout mice. J Pharmacol Exp Ther 2012;340:134-42
   PubMed Web of Science ®Google Scholar
• Mohar I, Stampher BD, Rademacher PM, et al. Acetaminophen-induced liver damage in mice is associated with gender-specific adduction of peroxiredoxin-6. Redox Biol 2014;2:377-87
   PubMed Web of Science ®Google Scholar
• Ni HM, Bockus A, Boggess N, et al. Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 2012;55:222-32
   PubMed Web of Science ®Google Scholar
• Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 2012;44:88-106
   PubMed Web of Science ®Google Scholar
• Pessayre D, Fromenty B, Berson A, et al. Central role of mitochondria in drug-induced liver injury. Drug Metab Rev 2012;44:34-87
   PubMed Web of Science ®Google Scholar
• Ray SD, Sorge CL, Raucy JL, et al. Early loss of large genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminophen-induced liver injury. Toxicol Appl Pharmacol 1990;106:346-51
   PubMed Web of Science ®Google Scholar
• Lawson JA, Fisher MA, Simmons CA, et al. Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice. Toxicol Appl Pharmacol 1999;156:179-86
   PubMed Web of Science ®Google Scholar
• Cover C, Mansouri A, Knight TR, et al. Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther 2005;315:879-87
   PubMed Web of Science ®Google Scholar
• Bajt ML, Cover C, Lemasters JJ, Jaeschke H. Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. Toxicol Sci 2006;94:217-25
   PubMed Web of Science ®Google Scholar
• Bajt ML, Farhood A, Lemasters JJ, Jaeschke H. Mitochondrial Bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity. J Pharmacol Exp Ther 2008;324:8-14
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61:1659-65
   PubMed Web of Science ®Google Scholar
• McGill MR, Sharpe MR, Williams CD, et al. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 2012;122:1574-83
   PubMed Web of Science ®Google Scholar
• Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012;143:1158-72
   PubMed Web of Science ®Google Scholar
• Lawson JA, Farhood A, Hopper RD, et al. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 2000;54:509-16
   PubMed Web of Science ®Google Scholar
• Holt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 2008;84:1410-21
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Williams CD, Ramachandran A, Bajt ML. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 2012;32:8-20
   PubMed Web of Science ®Google Scholar
• Williams CD, Bajt ML, Farhood A, Jaeschke H. Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice. Liver Int 2010;30:1280-92
   PubMed Web of Science ®Google Scholar
• Williams CD, Bajt ML, Sharpe MR, et al. Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. Toxicol Appl Pharmacol 2014;275:122-33
   PubMed Web of Science ®Google Scholar
• Roberts DW, Pumford NR, Potter DW, et al. A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther 1987;241:527-33
   PubMed Web of Science ®Google Scholar
• Pumford NR, Hinson JA, Potter DW, et al. Immunochemical quantitation of the 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice. J Pharmacol Exp Ther 1989;248:190-6
   PubMed Web of Science ®Google Scholar
• Davern TJ II, James LP, Hinson JA, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006;130:687-94
   PubMed Web of Science ®Google Scholar
• Davis M, Ideo G, Harrison NG, Williams R. Hepatic glutathione depletion and impaired bromosulphthalein clearance early after paracetamol overdose in man and the rat. Clin Sci Mol Med 1975;49:495-502
   PubMedGoogle Scholar
• Lauterburg BH, Mitchell JR. Therapeutic doses of acetaminophen stimulate the turnover of cysteine and glutathione in man. J Hepatol 1987;4:206-11
   PubMed Web of Science ®Google Scholar
• Gelotte CK, Auiler JF, Lynch JM, et al. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther 2007;81:840-8
   PubMed Web of Science ®Google Scholar
• James LP, Alonso EM, Hynan LS, et al. Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause. Pediatrics 2006;118:e676-e81
   PubMed Web of Science ®Google Scholar
• James LP, Letzig L, Simpson PM, et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos 2009;37:1779-84
   PubMed Web of Science ®Google Scholar
• McGill MR, Yan HM, Ramachandran A, et al. HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology 2011;53:974-82
   PubMed Web of Science ®Google Scholar
• Heard KJ, Green JL, James LP, et al. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol 2011;11:20
   PubMed Web of Science ®Google Scholar
• Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013;58:777-87
   PubMed Web of Science ®Google Scholar
• Schomaker S, Warner R, Bock J, et al. Assessment of emerging biomarkers of liver injury in human subjects. Toxicol Sci 2013;132:276-83
   PubMed Web of Science ®Google Scholar
• Wong SG, Card JW, Racz WJ. The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity. Toxicol Lett 2000;116:171-81
   PubMed Web of Science ®Google Scholar
• McGill MR, Li F, Sharpe MR, et al. Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch Toxicol 2014;88:391-401
   PubMed Web of Science ®Google Scholar
• Li M, Li C, Stanley CA, Smith TJ. The structure and allosteric regulation of mammalian glutamate dehydrogenase. Arch Biochem Biophys 2012;519:69-80
   PubMed Web of Science ®Google Scholar
• Chen C, Krausz KW, Shah YM, et al. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol 2009;22:699-707
   PubMed Web of Science ®Google Scholar
• Svetlov SI, Xiang Y, Oli MW, et al. Identification and preliminary validation of novel biomarkers of acute hepatic ischemia/reperfusion injury using dual-platform proteomic/degradomic approaches. Biomarkers 2006;11:355-69
   PubMed Web of Science ®Google Scholar
• Prima V, Cao M, Svetlov SI. ASS and SULT2A1 are novel and sensitive biomarkers of acute hepatic injury – a comparative study in animal models. J Liver 2013;2
   Google Scholar
• McGill MR, Cao M, Svetlov A, et al. Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 2014;19:222-30
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Stieber P, Förg T, et al. Apoptosis in serum of patients with solid tumors. Anticancer Res 1999;19:2721-4
   PubMed Web of Science ®Google Scholar
• Craig DG, Lee P, Pryde EA, et al. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int 2011;31:1127-36
   PubMed Web of Science ®Google Scholar
• Nagata S, Nagase H, Kawane K, et al. Degradation of chromosomal DNA during apoptosis. Cell Death Differ 2003;10:108-16
   PubMed Web of Science ®Google Scholar
• Caulin C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997;138:1379-94
   PubMed Web of Science ®Google Scholar
• Leers MP, Kölgen W, Björklund V, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 1999;187:567-72
   PubMed Web of Science ®Google Scholar
• Ueno T, Toi M, Bivén K, et al. Measurement of an apoptotic product in the sera of breast cancer patients. Eur J Cancer 2003;39:769-74
   PubMed Web of Science ®Google Scholar
• Olofsson MH, Ueno T, Pan Y, et al. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin cancer Res 2007;13:3198-206
   PubMed Web of Science ®Google Scholar
• Ulukaya E, Yilmaztepe A, Akgoz S, et al. The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival. Lung Cancer 2007;56:399-404
   PubMed Web of Science ®Google Scholar
• Otzurk B, Coskun U, Sancak B, et al. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. Int Immunopharmacol 2009;9:645-8
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Zein NN, Yerian LM, et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006;44:27-33
   PubMed Web of Science ®Google Scholar
• Bantel H, Lügering A, Heidemann J, et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004;40:1078-87
   PubMed Web of Science ®Google Scholar
• Zhang Z, Larner SF, Liu MC, et al. Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways. Apoptosis 2009;14:1289-98
   PubMed Web of Science ®Google Scholar
• Ren C, Zoltewicz S, Guingab-Cagmat J, et al. Different expression of ubiquitin C-terminal hydrolase-L1 and αII-spectrin in ischemic and hemorrhagic stroke: potential biomarkers in diagnosis. Brain Res 2013;1540:84-91
   PubMed Web of Science ®Google Scholar
• Jain P, Spaeder MC, Donofrio MT, et al. Detection of aplhaII-spectrin breakdown products in the serum of neonates with congenital heart disease. Pediatr Crit Care Med 2014;15:229-35
   PubMed Web of Science ®Google Scholar
• Gujral JS, Farhood A, Jaeschke H. Oncotic necrosis and caspase-dependent apoptosis during galactosamine-induced liver injury in rats. Toxicol Appl Pharmacol 2003;190:37-46
   PubMed Web of Science ®Google Scholar
• Antoine DJ, Williams DP, Kipar A, et al. High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicol Sci 2009;112:521-31
   PubMed Web of Science ®Google Scholar
• Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22:5551-60
   PubMed Web of Science ®Google Scholar
• Klune JR, Dhupar R, Cardinal J, et al. HMGB1: endogenous danger signaling. 2008;14:476-84
   Google Scholar
• Yang H, Antoine DJ, Andersson U, Tracey KJ. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 2013;93:865-73
   PubMed Web of Science ®Google Scholar
• Antoniades CG, Quaglia A, Taams LS, et al. Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology 2012;56:735-46
   PubMed Web of Science ®Google Scholar
• Harrill AH, Roach J, Fier I, et al. The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. Clin Pharmacol Ther 2012;92:214-20
   PubMed Web of Science ®Google Scholar
• James LP, Simpson PM, Farrar HC, et al. Cytokines and toxicity in acetaminophen overdose. J Clin Pharmacol 2005;45:1165-71
   PubMed Web of Science ®Google Scholar
• Craig DG, Lee P, Pryde EA, et al. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury. Eur J Gastroenterol Hepatol 2013;25:359-67
   PubMed Web of Science ®Google Scholar
• Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. Semin Respir Crit Care Med 2012;33:80-95
   PubMed Web of Science ®Google Scholar
• Antoniades CG, Berry PA, Wendon JA, et al. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008;49:845-61
   PubMed Web of Science ®Google Scholar
• Ambros V. The evolution of our thinking about microRNAs. Nat Med 2008;14:1036-40
   PubMed Web of Science ®Google Scholar
• Kosaka N, Yoshioka Y, Hagiwara K, et al. Trash or treasure: extracellular microRNAs and cell-to-cell communication. Front Genet 2013;4:173; eCollection 2013
   PubMedGoogle Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-18
   PubMed Web of Science ®Google Scholar
• Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694
   PubMed Web of Science ®Google Scholar
• Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008;54:482-90
   PubMed Web of Science ®Google Scholar
• Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS one 2008;3:e3148
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009;106:4402-7
   PubMed Web of Science ®Google Scholar
• Starkey Lewis PJ, Dear J, Platt V, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011;54:1767-76
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jia Y, Zheng R, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010;56:1830-8
   PubMed Web of Science ®Google Scholar
• Cermelli S, Ruggieri A, Marrero JA, et al. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011;6:e23937
   PubMed Web of Science ®Google Scholar
• Roderburg C, Mollnow T, Bongaerts B, et al. Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One 2012;7:e32999
   PubMed Web of Science ®Google Scholar
• Thulin P, Nordahl G, Gry M, et al. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int 2013. [ Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Clarke JD, Sharapova T, Lake AD, et al. Circulating microRNA 122 in the methionine- and choline-deficient mouse model of non-alcoholic steatohepatitis. J Appl Toxicol 2013. [ Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Woolbright BL, Antoine DJ, Jenkins RE, et al. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice. Toxicol Appl Pharmacol 2013;273:524-31
   PubMed Web of Science ®Google Scholar
• Su YW, Chen X, Jiang ZZ, et al. A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats. PLoS One 2012;7:e37395
   PubMed Web of Science ®Google Scholar
• Ward J, Bala S, Petrasek J, Szabo G. Plasma microRNA profiles distinguish lethal injury in acetaminophen toxicity: a research study. World J Gastroenterol 2012;18:2798-804
   PubMed Web of Science ®Google Scholar
• Laudadio I, Manfroid I, Achouri Y, et al. A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation. Gastroenterology 2012;142:119-29
   PubMed Web of Science ®Google Scholar
• Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol 2014. [ Epub ahead of print]
   Web of Science ®Google Scholar
• Gottwein E. Roles of microRNAs in the life cycles of mammalian viruses. Curr Top Microbiol Immunol 2013;371:201-27
   PubMed Web of Science ®Google Scholar
• Fernández-Hernando C, Ramírez CM, Goedeke L, Suárez Y. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 2013;33:178-85
   PubMed Web of Science ®Google Scholar
• McDaniel K, Herrera L, Zhou T, et al. The functional role of microRNAs in alcoholic liver injury. J Cell Mol Biol 2014;18:197-207
   Web of Science ®Google Scholar
• Ong MM, Latchoumycandane C, Boelsterli UA. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. Toxicol Sci 2007;97:205-13
   PubMed Web of Science ®Google Scholar
• Harrill AH, Ross PK, Gatti DM, et al. Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory rodent strain diversity panel. Toxicol Sci 2009;110:235-43
   PubMed Web of Science ®Google Scholar
• Ng W, Lobach AR, Zhu X, et al. Animal models of idiosyncratic drug reactions. Adv Pharmacol 2012;63:81-135
   PubMedGoogle Scholar
• Metushi IG, Uetrecht J. Isoniazid-induced liver injury and immune response in mice. J Immunotoxicol 2013. [ Epub ahead of print]
   Web of Science ®Google Scholar
• Fujimoto K, Kumagai K, Ito K, et al. Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen. Toxicol Pathol 2009;37:193-200
   PubMed Web of Science ®Google Scholar
• McGill MR, Williams CD, Xie Y, et al. Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 2012;264:387-94
   PubMed Web of Science ®Google Scholar
• Donato MT, Lahoz A, Castell JV, Gόmez-Lechόn MJ. Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 2008;9:1-11
   PubMed Web of Science ®Google Scholar
• Hart SN, Li Y, Nakamoto K, et al. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab Dispos 2010;38:988-94
   PubMed Web of Science ®Google Scholar
• Lin J, Schyschka L, Mühl-Benninghaus R, et al. Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism. Arch Toxicol 2012;86:87-95
   PubMed Web of Science ®Google Scholar
• Guillouzo A, Corlu A, Aninat C, et al. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 2007;168:66-73
   PubMed Web of Science ®Google Scholar
• Godoy P, Hewitt NJ, Albrecht U, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013;87:1315-530
   PubMed Web of Science ®Google Scholar
• Morel F, Beaune PH, Ratanasavanh D, et al. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur J Biochem 1990;191:437-44
   PubMedGoogle Scholar
• Anthérieu S, Chesné C, Li R, et al. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos 2010;38:516-25
   PubMed Web of Science ®Google Scholar
• Marshall KD, Edwards MA, Krenz M, et al. Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes. Am J Physiol Cell Physiol 2014;306:C639-547
   PubMed Web of Science ®Google Scholar
• Royo F, Schlangen K, Palomo L, et al. Transcriptome of extracellular vesicles released by hepatocytes. PLoS One 2013;8:e68693
   PubMed Web of Science ®Google Scholar
• Henderson NC, Pollock KJ, Frew J, et al. Critical role of c-Jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 2007;56:982-90
   PubMed Web of Science ®Google Scholar